Hydroa vacciniforme-like lymphoma: A chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma

Blood

Volumn 122, Issue 18, 2013, Pages 3101-3110

  Quintanilla Martinez, Leticia ^a   Ridaura, Cecilia ^b   Nagl, Florian ^a   Sáez De ocariz, Marimar ^b   Durán McKinster, Carola ^b   Ruiz Maldonado, Ramon ^b   Alderete, Georgia ^b   Grube, Peter ^b   Lome Maldonado, Carmen ^c   Bonzheim, Irina ^a   Fend, Falko ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^c INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; CYCLOPHOSPHAMIDE; STEROID; THALIDOMIDE; VIRUS RNA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; DISEASE COURSE; DISEASE SEVERITY; EDEMATOUS SCARRING VASCULITIC PANNICULITIS; EPSTEIN BARR VIRUS; FEMALE; FEVER; FOLLOW UP; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; HYDROA VACCINIFORME; HYDROA VACCINIFORME LIKE LYMPHOMA; HYPERSENSITIVITY; IMMUNOPHENOTYPING; INSECT BITE; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; LYMPHOMA; MALE; NATURAL KILLER CELL; NATURAL KILLER T CELL; PANNICULITIS; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE; REMISSION; SCHOOL CHILD; SKIN DEFECT; STEROID THERAPY; TREATMENT RESPONSE;

EID: 84888209580     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-05-502203     Document Type: Article

References (33)

1. Gupta G, Man I, Kemmett D. Hydroa vacciniforme: a clinical and follow-up study of 17 cases. J Am Acad Dermatol. 2000;42(2 Pt 1):208-213.
2. Ruiz-Maldonado R, Parrilla FM, Orozco-Covarrubias ML, Ridaura C, Tamayo Sanchez L, Duran McKinster C. Edematous, scarring vasculitic panniculitis: a new multisystemic disease with malignant potential. J Am Acad Dermatol. 1995;32(1):37-44.
3. Magaña M, Sangüeza P, Gil-Beristain J, et al. Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma. J Am Acad Dermatol. 1998;38(4):574-579.
4. Barrionuevo C, Anderson VM, Zevallos-Giampietri E, et al. Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru. Appl Immunohistochem Mol Morphol. 2002;10(1):7-14.
5. Tabata N, Aiba S, Ichinohazama R, et al. Hydroa vacciniforme-like lymphomatoid papulosis in a Japanese child: a new subset. J Am Acad Dermatol. 1995;32(2 Pt 2):378-381.
6. Gu H, Chang B, Qian H, Li G. A clinical study on severe hydroa vacciniforme. Chin Med J (Engl). 1996;109(8):645-647.
7. Iwatsuki K, Ohtsuka M, Akiba H, Kaneko F. Atypical hydroa vacciniforme in childhood: from a smoldering stage to Epstein-Barr virus-associated lymphoid malignancy. J Am Acad Dermatol. 1999;40(2 Pt 1):283-284.
8. Cho KH, Kim CW, Lee DY, Sohn SJ, Kim DW, Chung JH. An Epstein-Barr virus-associated lymphoproliferative lesion of the skin presenting as recurrent necrotic papulovesicles of the face. Br J Dermatol. 1996;134(4):791-796.
9. Doeden K, Molina-Kirsch H, Perez E, Warnke R, Sundram U. Hydroa-like lymphoma with CD56 expression. J Cutan Pathol. 2008;35(5):488-494.
10. Iwatsuki K, Xu Z, Takata M, et al. The association of latent Epstein-Barr virus infection with hydroa vacciniforme. Br J Dermatol. 1999;140(4):715-721.
11. Quintanilla-Martinez L, Kimura H, Jaffe ES. EBV-positive T-cell lymphoproliferative disorders of childhood. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer (IARC), 2008:278-260.
12. Cho KH, Kim CW, Heo DS, et al. Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions. Clin Exp Dermatol. 2001;26(3):242-247.
13. Kawa K, Okamura T, Yagi K, Takeuchi M, Nakayama M, Inoue M. Mosquito allergy and Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease. Blood. 2001;98(10):3173-3174.
14. Xu Z, Lian S. Epstein-Barr virus-associated hydroa vacciniforme-like cutaneous lymphoma in seven Chinese children. Pediatr Dermatol. 2010;27(5):463-469.
15. Iwatsuki K, Satoh M, Yamamoto T, et al. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol. 2006;142(5):587-595.
16. Wu YH, Chen HC, Hsiao PF, Tu MI, Lin YC, Wang TY. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child. Int J Dermatol. 2007;46(10):1081-1086.
17. Lee HY, Baek JO, Lee JR, Park SH, Jeon IS, Roh JY. Atypical hydroa vacciniforme-like Epstein-Barr virus associated T/NK-cell lymphoproliferative disorder. Am J Dermatopathol. 2012;34(8):e119-e124.
18. Oono T, Arata J, Masuda T, Ohtsuki Y. Coexistence of hydroa vacciniforme and malignant lymphoma. Arch Dermatol. 1986;122(11):1306-1309.
19. Goldgeier MH, Nordlund JJ, Lucky AW, Sibrack LA, McCarthy MJ, McGuire J. Hydroa vacciniforme: diagnosis and therapy. Arch Dermatol. 1982;118(8):588-591.
20. Sonnex TS, Hawk JL. Hydroa vacciniforme: a review of ten cases. Br J Dermatol. 1988;118(1):101-108.
21. Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol. 2009;20(9):1472-1482.
22. Cho KH, Lee SH, Kim CW, et al. Epstein-Barr virus-associated lymphoproliferative lesions presenting as a hydroa vacciniforme-like eruption: an analysis of six cases. Br J Dermatol. 2004;151(2):372-380.
23. Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001;98(2):280-286.
24. Kimura H, Ito Y, Kawabe S, et al. EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases. Blood. 2012;119(3):673-686.
25. Quintanilla-Martinez L, Kumar S, Fend F, et al. Fulminant EBV (1) T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood. 2000;96(2):443-451.
26. McCarthy KP, Sloane JP, Kabarowski JH, Matutes E, Wiedemann LM. A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene. Diagn Mol Pathol. 1992;1(3):173-179.
27. Trainor KJ, Brisco MJ, Wan JH, Neoh S, Grist S, Morley AA. Gene rearrangement in B- and T-lymphoproliferative disease detected by the polymerase chain reaction. Blood. 1991;78(1):192-196.
28. Van Dongen JJ, Langerak AW, Brüggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17(12):2257-2317.
29. Chen HH, Hsiao CH, Chiu HC. Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma. Br J Dermatol. 2002;147(3):587-591.
30. Wada T, Toga A, Sakakibara Y, et al. Clonal expansion of Epstein-Barr virus (EBV)-infected gd T cells in patients with chronic active EBV disease and hydroa vacciniforme-like eruptions. Int J Hematol. 2012;96(4):443-449.
31. Hirai Y, Yamamoto T, Kimura H, et al. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected gdT cells. J Invest Dermatol. 2012;132(5):1401-1408.
32. Rodríguez-Pinilla SM, Barrionuevo C, Garcia J, et al. EBV-associated cutaneous NK/T-cell lymphoma: review of a series of 14 cases from Peru in children and young adults. Am J Surg Pathol. 2010;34(12):1773-1782.
33. Ishihara S, Ohshima K, Tokura Y, et al. Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells. Jpn J Cancer Res. 1997;88(1):82-87.